Effect of ozone therapy in post COVID-19 lung sequels

Investigating the consequences of ozone therapy in hypoxia of oxygen-dependent patients affected by COVID-19 after discharge from the hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220814055690N1

Enrollment

206

Registered

2024-03-22

Start date

2024-04-03

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Post COVID fibrosis/ inflammatory lung disease. Condition 2: COVID-19 disease. Abnormal findings on diagnostic imaging of lung COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Patients referred to ozone therapy centers affiliated to Baqiyatullah University located in Tehran and Najaf Abad, with a history of contracting COVID-19, who have

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Filling out the informed consent form Post COVID-19 oxygen dependent patients

Exclusion criteria

Exclusion criteria: Hypersensitivity to ozone Albumin less than 3.4 Platelets less than 60,000 Bleeding and coagulation disorders Uncontrolled hyperthyroidism

Design outcomes

Primary

Measure	Time frame
The percentage of improvement of pulmonary involvement in CT scan reports of patients. Timepoint: At the beginning of the study and 6 months after the received treatment. Method of measurement: CT scan report of patients.;Spirometry diagram. Timepoint: At the beginning of the study and 6 months after the received treatment. Method of measurement: Interpretation of spirometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Abbaspour

Bagheiat-allah University of Medical Sciences

Sina.abbaspour75@gmail.com+98 13 4277 3001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026